Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. USO
4. KBH
5. HTZ
6. QCOM
7. SPY
8. HON
9. SPCX
10. TTWO

Go back to Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results

Fulcrum Therapeutics Inc. (FULC) Tops Q4 EPS by 15c

March 3, 2022 7:02 AM EST

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q4 EPS of ($0.58), $0.15 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $5.1 million versus the consensus estimate of $2.68 million.

As of December 31, 2021, cash, cash equivalents, and marketable securities were $218.2 million, as compared to $112.9... More